Literature DB >> 22766474

Comparative studies of polyethylene glycol-modified liposomes prepared using different PEG-modification methods.

Koji Nakamura1, Keiko Yamashita, Yuki Itoh, Keisuke Yoshino, Shigenori Nozawa, Hiroaki Kasukawa.   

Abstract

To address the issue of excess polyethylene glycol (PEG)-lipid degradation observed when PEG-modified liposomes are prepared using the pH-gradient method, a concept using a novel PEG-modification method, called the post-modification method, was proposed and evaluated. To assess the proof concept, a preservation-stability study and a pharmacokinetic study were performed that compared the conventional PEG-modification method, called the pre-modification method, with the post-modification method. The results show that PEG-lipid degradation could be markedly inhibited in the post-modification method. Furthermore, the post-modification method could be used without any manufacturing process difficulties, especially with high PEG-lipid content. In addition, a higher blood circulation capability was observed in the post-modification method. Through comparative studies, it was found that the post-modification method was advantageous compared to the pre-modification method. In conclusion, the post-modification method has the potential to be a novel PEG-modification method that can achieve a higher preservation stability of PEG-lipid, a greater ease of manufacturing, and a higher blood circulation capability, especially in the manufacturing of pH-gradient liposomal products.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22766474     DOI: 10.1016/j.bbamem.2012.06.019

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  26 in total

1.  Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo.

Authors:  Okhil K Nag; Vivek R Yadav; Andria Hedrick; Vibhudutta Awasthi
Journal:  Int J Pharm       Date:  2013-02-16       Impact factor: 5.875

2.  Controlling the Biological Fate of Liposomal Spherical Nucleic Acids Using Tunable Polyethylene Glycol Shells.

Authors:  Wuliang Zhang; Cassandra E Callmann; Chad A Mirkin
Journal:  ACS Appl Mater Interfaces       Date:  2021-09-21       Impact factor: 10.383

3.  Dual functionalized liposome-mediated gene delivery across triple co-culture blood brain barrier model and specific in vivo neuronal transfection.

Authors:  Bruna Dos Santos Rodrigues; Hiroshi Oue; Amrita Banerjee; Takahisa Kanekiyo; Jagdish Singh
Journal:  J Control Release       Date:  2018-07-31       Impact factor: 9.776

4.  The bifunctional liposomes constructed by poly(2-ethyl-oxazoline)-cholesteryl methyl carbonate: an effectual approach to enhance liposomal circulation time, pH-sensitivity and endosomal escape.

Authors:  Huan Xu; Wei Zhang; Yan Li; Fei F Ye; Peng P Yin; Xiu Yu; Mei N Hu; Yuan S Fu; Che Wang; De J Shang
Journal:  Pharm Res       Date:  2014-05-08       Impact factor: 4.200

Review 5.  PEGylation as a strategy for improving nanoparticle-based drug and gene delivery.

Authors:  Jung Soo Suk; Qingguo Xu; Namho Kim; Justin Hanes; Laura M Ensign
Journal:  Adv Drug Deliv Rev       Date:  2015-10-09       Impact factor: 15.470

6.  Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting.

Authors:  Federico Perche; Vladimir P Torchilin
Journal:  J Drug Deliv       Date:  2013-03-07

7.  Optimization of a siRNA Carrier Modified with a pH-Sensitive Cationic Lipid and a Cyclic RGD Peptide for Efficiently Targeting Tumor Endothelial Cells.

Authors:  Tomoya Hada; Yu Sakurai; Hideyoshi Harashima
Journal:  Pharmaceutics       Date:  2015-09-14       Impact factor: 6.321

8.  Surface engineering of liposomes for stealth behavior.

Authors:  Okhil K Nag; Vibhudutta Awasthi
Journal:  Pharmaceutics       Date:  2013-10-25       Impact factor: 6.321

9.  A brief perspective on the diverging theories of lymphatic targeting with colloids.

Authors:  Karthik Siram; Gregory Marslin; Chellan Vijaya Raghavan; Krishnamoorthy Balakumar; Habibur Rahman; Gregory Franklin
Journal:  Int J Nanomedicine       Date:  2016-06-15

10.  Anti-EphA10 antibody-conjugated pH-sensitive liposomes for specific intracellular delivery of siRNA.

Authors:  Xinlong Zang; Huaiwei Ding; Xiufeng Zhao; Xiaowei Li; Zhouqi Du; Haiyang Hu; Mingxi Qiao; Dawei Chen; Yuihui Deng; Xiuli Zhao
Journal:  Int J Nanomedicine       Date:  2016-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.